Amid the evolving landscape of the pharmaceutical sector, Supernus Pharmaceuticals (SUPN) has delivered impressive growth, with its stock price rising 31% over the past year. However, despite the recent rally, Supernus still trades 20% below its 2018 highs, leading some investors to question whether the stock can sustain its momentum or if it is time to scale back. Aristotle Capital Boston, a significant investor in the company, recently disclosed in a SEC filing on November 14, 2025, that it had sold 503,122 shares of Supernus in the third quarter of 2025. This move resulted in a $10.9 million reduction in...

Amid the evolving landscape of the pharmaceutical sector, Supernus Pharmaceuticals (SUPN) has delivered impressive growth, with its stock price rising 31% over the past year. However, despite the recent rally, Supernus still trades 20% below its 2018 highs, leading some investors to question whether the stock can sustain its momentum or if it is time to scale back. Aristotle Capital Boston, a significant investor in the company, recently disclosed in a SEC filing on November 14, 2025, that it had sold 503,122 shares of Supernus in the third quarter of 2025. This move resulted in a $10.9 million reduction in...

Markets opened cautiously this morning as traders prepared for the November Consumer Price Index release at 8:30 AM Eastern Time. A senior financial analyst at Logirium examines why this particular inflation report carries more uncertainty than usual and what investors should focus on beyond the headline numbers. The Bureau of Labor Statistics will publish November inflation data without the usual October baseline. The government shutdown that stretched through October prevented critical data collection. This creates a statistical gap that makes standard month-over-month comparisons impossible for many categories. The Data Gap Problem Wall Street typically relies on monthly inflation changes to...

Technology shares suffered their worst session in months on Wednesday as investors reassessed the massive capital requirements behind artificial intelligence infrastructure buildouts. The Nasdaq 100 plunged 1.9% while the S&P 500 dropped 1.2%, with both indexes breaching technical support levels that had held for weeks. Logirium‘s lead financial analyst examines the sharp technology sector retreat that erased billions in market value as infrastructure financing concerns spread across Wall Street trading desks. Oracle’s stock fell 5.4% after reports emerged that its primary infrastructure partner withdrew from a $10 billion data center project. The news sent shockwaves through related sectors. The Financing...